CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVS

Ribociclib

Phase 3
Novartis AG (NVS)

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
NVSPhase 3

Ribociclib Phase 3 Est. Readout

Ribociclib
Q3 2027~Q
CT.gov
00%
Apr '27
NVSPhase 2

Ribociclib Phase 2 Est. Readout

Ribociclib
Apr 2027~
CT.gov
00%
Competitive Landscape

1 competitor in Early Breast Cancer

View Full Landscape
Drug Information

Target Indication

Early Breast Cancer

Clinical Trial

NCT03701334

Last updated: 1/10/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.